SCTX
Scribe Therapeutics Inc.
19.20$
+9.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| -79.5% | -135.4% | -338.3% | -278.3% | |
| 5.0% | 17.1% | 34.6% | 40.9% | |
| 3.9% | 13.8% | 88.2% | 11.8% | |
| -86.0% | 32.1% | 72.8% | -49.6% | |
| 2.9% | 9.0% | 0.8% | 0.5% | |
| 0.0% | 1.1% | -18.4% | -71.8% | |
| 42.6% | -80.0% | 339.7% | 792.8% | |
| -82.4% | -144.3% | -339.1% | -278.8% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.